Latest News

December 6, 2022

Study Finds Latest Neuro Meds Have Low Usage By Doctors

Michigan Medicine's Health Lab blog sat down with Brian Callaghan, M.D., M.S., who led a team that discovered that high costs and similar effectiveness (to current medications) have led doctors to choose to not utilize the latest neurologic drug therapies.

October 21, 2022

ALS Research Featured on Detroit Free Press Cover

The article covers recently published findings by a team led by Drs. Eva Feldman and Stephen Goutman and Eva Feldman found that work as a welder, production line work, and jobs that involve exposure to metals, solvents or pesticides are associated with a higher risk for developing ALS.

October 17, 2022

The National Academy of Medicine Annual Meeting 2022

There was quite a large contingent from Michigan Medicine at the National Academy of Medicine’s Annual Meeting this year, including a number of new inductees. The focus of the events this year was on the importance of climate change and health.

October 12, 2022

Breaking free of opioids

Brian Callaghan, M.D., sat down with Michigan Medicine's Michigan Health blog to share alternative treatments for chronic pain and the importance of steering clear of opioids.

logo for the U-M Center for Global Health Equity
October 7, 2022

Center for Global Health Equity Covers Dr. Feldman Award

Three members from the University of Michigan's Center for Global Health Equity recently received awards for their impact on "teaching, mentoring service and scholarship." The Center celebrates the trio that included Eva Feldman, M.D., Ph.D., who won a Distinguished University Professorship.

September 29, 2022

Lipid Profile Predicts Nerve Damage Risk In Type 2 Diabetes

Michigan Medicine's Health Lab's Lab Report shared new findings from the NeuroNetwork for Emerging therapies that certain blood lipid profiles can predict the risk of nerve damage 10 years later in patients with type 2 diabetes.

September 23, 2022

Grant to Uncover New Therapy Targets for Neuropathy

The NeuroNetwork for Emerging Therapies, led by primary investigators Eva Feldman, M.D., Ph.D., and Junghuk Hur, Ph.D., M.S., will look at dietary interventions and the mechanisms underlying their benefits with a new R01 grant from the National Institute of Diabetes and Digestive and Kidney Diseases.

September 22, 2022

New Guidelines for Painful Diabetic Neuropathy

On site of the American Association of Neuromuscular & Electrodiagnostic Medicine (AANEM) this morning, Brian Callaghan, M.D., M.S., shared via video a few key points from the talk he had just finished that shared the new American Academy of Neurology (ANN) Painful Diabetic Neuropathy guidelines.

picture of production worker welding
September 16, 2022

ALS Risk Higher Among Production Workers

Michigan Medicine's Health Lab's Lab Report shared a recent study by Stephen Goutman, M.D., that found that ALS risk is higher among production workers, those exposed to metals, and volatile compounds on the job due to Michigan's legacy industry and agriculture.

CDC logo
September 6, 2022

CDC Features ALS Directors

Portraits of Drs. Eva Feldman and Stephen Goutman, directors of the ALS Center of Excellence and Pranger ALS Clinic respectively, take center stage in newly launched visuals on the research page of the National ALS Registry, part of the Agency for Toxic Substances and Disease Registry (ATSDR) at the Centers for Disease Control and Prevention

Pages